Search clinical trials for: P63

Total 10 results

Assiut University

Completed

Abnormal Uterine Bleeding and Progestin-only Contraceptives

Contraception

Egypt
Celltrion

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

SARS-CoV-2 Infection

Poland
Celltrion

Withdrawn

To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen

COVID-19
Dartmouth-Hitchcock Medical Center

Terminated

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Carcinoma

United States
Ruijin Hospital
Regend Therapeutics

Not yet recruiting

Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis

Bronchiectasis

China
Wright State University

Completed

Pilot Studies Testing Levels of P63 in Psoriasis Skin Lesions

Psoriasis

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; North Shore...

Completed

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response

Breast Cancer

United States
Fondation Ophtalmologique Adolphe de Rothschild
Institut National de la Santé Et de la Recherche Médicale, France

Terminated

Ability of a Molecule (Prima) to Restore Physiological Differentiation in Epithelium Expressing Gene p63 (PRIMAculture)

Ectodermal Dysplasia

France
Ruijin Hospital
Regend Therapeutics

Completed

Autologous Transplantation of Bronchial Basal Cells for Treatment of Bronchiectasis

Bronchiectasis

China
Rambam Health Care Campus

Unknown

Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas

Lung Adenocarcinoma | Pancreatic Ductal Adenocarcinoma | Breast Adenocarcinoma

3

Subscribe